Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report

Thymic carcinoma is a rare malignant tumor with a poor prognosis. No standard treatment is currently available. The present case was a 64-year-old male smoker with no symptoms referred to our hospital because of abnormal chest radiological findings. The CT study showed a tumor between the anterior m...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishii, Yoichi, Furuhashi, Kazuki, Ito, Kentaro, Sakaguchi, Tadashi, Suzuki, Yuta, Fujiwara, Kentaro, Yasuma, Taro, Kobayashi, Tetsu, D’Alessandro-Gabazza, Corina N., Gabazza, Esteban C., Taguchi, Osamu, Hataji, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319623/
https://www.ncbi.nlm.nih.gov/pubmed/35890187
http://dx.doi.org/10.3390/ph15070889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319623/
https://www.ncbi.nlm.nih.gov/pubmed/35890187
http://dx.doi.org/10.3390/ph15070889

Ejemplares similares